News

Back
June 7, 2021

Salarius Pharmaceuticals Presents New Research Data Demonstrating Seclidemstat’s Safety, Dosing, and Drug Activity at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

Contact

Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com
Download PDF